This list is based on the watchlists of people on Stock Events who follow ONCO.NEO. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company's lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. The company has a strategic collaboration with Nucro-Technics Inc. for the development of bioanalytical methods to support preclinical pharmacokinetic and biodistribution studies. Onco-Innovations Limited is headquartered in Calgary, Canada.
FAQs
What is Onco Innovations stock price today?▼
The current price of ONCO.NEO is C$0.24 CAD — it has increased by +4.35% in the past 24 hours. Watch Onco Innovations stock price performance more closely on the chart.
What is Onco Innovations stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NEO Exchange exchange Onco Innovations stocks are traded under the ticker ONCO.NEO.
Is Onco Innovations stock price growing?▼
ONCO.NEO stock has fallen by -14.29% compared to the previous week, the month change is a -35.14% fall, over the last year Onco Innovations has showed a -85.54% decrease.
What is Onco Innovations market cap?▼
Today Onco Innovations has the market capitalization of 16.39M
What is Onco Innovations revenue for the last year?▼
Onco Innovations revenue for the last year amounts to 110,000 CAD.
What is Onco Innovations net income for the last year?▼
ONCO.NEO net income for the last year is -10.78M CAD.
In which sector is Onco Innovations located?▼
Onco Innovations operates in the Health & Wellness sector.
When did Onco Innovations complete a stock split?▼
Onco Innovations has not had any recent stock splits.
Where is Onco Innovations headquartered?▼
Onco Innovations is headquartered in Calgary, Canada.